Cargando…

d-chiro-inositol Induces Ovulation in Non-Polycystic Ovary Syndrome (PCOS), Non-Insulin-Resistant Young Women, Likely by Modulating Aromatase Expression: A Report of 2 Cases

Case series Patients: Female, 19-year-old • Female, 23-year-old Final Diagnosis: Anovulation Symptoms: Oligomenorrhea Medication: — Clinical Procedure: — Specialty: Obstetrics and Gynecology OBJECTIVE: Unknown etiology BACKGROUND: Anovulation consists in the lack of oocyte release during the menstru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espinola, Maria Salomé Bezerra, Laganà, Antonio Simone, Bilotta, Gabriele, Gullo, Giuseppe, Aragona, Cesare, Unfer, Vittorio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503791/ https://www.ncbi.nlm.nih.gov/pubmed/34615846 http://dx.doi.org/10.12659/AJCR.932722

Ejemplares similares

D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study
por: Monastra, Giovanni, et al.
Publicado: (2021)

D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study
por: Porcaro, Giuseppina, et al.
Publicado: (2023)

Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside
por: Nordio, Maurizio, et al.
Publicado: (2023)

Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
por: Unfer, Vittorio, et al.
Publicado: (2023)

PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
por: Monastra, Giovanni, et al.
Publicado: (2021)

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)

Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk
por: Bezerra Espinola, Maria Salome, et al.
Publicado: (2021)

Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
por: Iervolino, Matteo, et al.
Publicado: (2021)

New Insights into the Activities of D-Chiro-Inositol: A Narrative Review
por: Gambioli, Riccardo, et al.
Publicado: (2021)

CONCERN: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2012)

Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS
por: Unfer, Vittorio, et al.
Publicado: (2020)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
por: Bizzarri, Mariano, et al.
Publicado: (2023)

Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018)

The Effect of Insulin Resistance on Ovulation Induction With Clomiphene Citrate in Non-polycystic Ovary Syndrome (PCOS) Women
por: Karnatak, Ruchi, et al.
Publicado: (2022)

D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2)
por: Monastra, Giovanni, et al.
Publicado: (2023)

Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
por: Kamenov, Zdravko, et al.
Publicado: (2023)

A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System
por: Beresniak, Ariel, et al.
Publicado: (2023)

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review
por: Davinelli, Sergio, et al.
Publicado: (2020)

Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial
por: Bahadur, Anupama, et al.
Publicado: (2021)

A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
por: Benelli, Elena, et al.
Publicado: (2016)

A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?
por: Unfer, Vittorio, et al.
Publicado: (2023)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results
por: Fedeli, Valeria, et al.
Publicado: (2023)

Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
por: Tortolini, Cristina, et al.
Publicado: (2023)

Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
por: Unfer, Vittorio, et al.
Publicado: (2016)

Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
por: Unfer, Vittorio, et al.
Publicado: (2017)

Effect of Oral High Molecular Weight Hyaluronic Acid (HMWHA), Alpha Lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D Supplementation in Pregnant Women: A Retrospective Observational Pilot Study
por: Parente, Eligio, et al.
Publicado: (2023)

The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
por: Pintaudi, Basilio, et al.
Publicado: (2016)

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
por: Yang, Hyun, et al.
Publicado: (2022)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome
por: Cheang, Kai I., et al.
Publicado: (2016)

Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols
por: Laganà, Antonio Simone, et al.
Publicado: (2016)

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
por: Troisi, Jacopo, et al.
Publicado: (2019)

D-Chiro-Inositol Regulates Insulin Signaling in Human Adipocytes
por: Montt-Guevara, Maria Magdalena, et al.
Publicado: (2021)

The effect of D-chiro-inositol on renal protection in diabetic mice
por: Fan, Chunxue, et al.
Publicado: (2022)

Reconsidering the Polycystic Ovary Syndrome (PCOS)
por: Gleicher, Norbert, et al.
Publicado: (2022)

Inositols in PCOS
por: Kamenov, Zdravko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7trfi5ksvsos3h4rvd2s6586fo